Legal Opinion
Amgen Inc. v. Hospira, Inc.
District Court, D. Delaware
Decided August 27, 2018No. Civil Action No. 15-cv-839-RGAPublishedCited by 14 opinions
1Opinion of the Court
ANDREWS, U.S. DISTRICT JUDGE
On September 18, 2015, Amgen, Inc. and Amgen Manufacturing, Limited (collectively, "Amgen") sued Hospira, Inc. for infringement of U.S. Patent No. 5,856,298 under 35 U.S.C. §§ 271(a) and 271(e)(2)(C) and for infringement of U.S. Pat. No. 5,756,349 under § 271(a). (D.I. 1). The '298 patent and the '349 patent cover erythropoietin ("epoetin" or "EPO") isoforms and aspects of their production. Hospira submitted Biologic License Application ("BLA") No. 125-545 to the FDA in December 2014, seeking FDA approval for Hospira's epoetin biosimilar product. (D.I. 290-1 at 1).…
2Cases cited37 opinions
- Allied Chemical Corp. v. Daiflon, Inc.Supreme Court of the United States · 1980
- General Motors Corp. v. Devex Corp.Supreme Court of the United States · 1983
- Halo Electronics, Inc. v. Pulse Electronics, Inc.Supreme Court of the United States · 2016
- Marra v. Philadelphia Housing AuthorityCourt of Appeals for the Third Circuit · 2007
- Publicker Industries, Inc. v. CohenCourt of Appeals for the Third Circuit · 1984
32 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- AgroFresh Inc. v. Essentiv LLCDistrict Court, D. Delaware · 2020
- ArcherDX, LLC v. QIAGEN Sciences, LLCDistrict Court, D. Delaware · 2022
- C.J. HUGHES CONSTRUCTION COMPANY INC. v. EQM GATHERING OPCO, LLCDistrict Court, W.D. Pennsylvania · 2022
- FREEDOM MORTGAGE CORPORATION v. LOANCARE, LLCDistrict Court, D. New Jersey · 2024
- Gavrieli Brands LLC v. Soto Massini (USA) Corp.District Court, D. Delaware · 2020
9 more not listed; retrieve them via the Exa API.